Biocorp
Designs, develops, and manufactures medical devices and drug delivery systems.
ALCOR | PA
Overview
Corporate Details
- ISIN(s):
- FR0012788065
- LEI:
- 969500TKUAME6031UQ32
- Country:
- France
- Address:
- PARC INDUSTRIEL TECH LAVAUR LA BECHADE, 63500 ISSOIRE
- Website:
- https://biocorpsys.com
- Sector:
- Manufacturing
Description
Biocorp designs, develops, and manufactures medical devices and drug delivery systems for the pharmaceutical industry. The company specializes in combining precision engineering with connected technologies to improve patient treatment adherence and outcomes. Its portfolio includes both connected and non-connected devices, such as smart caps for inhalers (Inspair), pen injectors, and systems for drug reconstitution and safety. Biocorp manages the entire value chain, from research and development to manufacturing and final packaging, leveraging its expertise in plastics processing and advanced technological innovation. Since October 2023, Biocorp has been a subsidiary of Novo Nordisk.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-01-25 07:30 |
Informations privilégiées / Autres communiqués
|
French | 135.9 KB | ||
| 2024-01-25 07:30 |
Inside Information / Other news releases
|
English | 158.2 KB | ||
| 2023-10-03 10:59 |
Franchissement de seuils
|
French | 202.6 KB | ||
| 2023-10-02 17:30 |
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 116.9 KB | ||
| 2023-10-02 14:04 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Autres comm…
|
French | 146.3 KB | ||
| 2023-09-06 11:20 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 136.6 KB | ||
| 2023-09-04 18:00 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 306.3 KB | ||
| 2023-09-04 18:00 |
Inside Information / News release on accounts, results
|
English | 325.3 KB | ||
| 2023-08-28 14:00 |
Franchissement de seuil
|
French | 201.1 KB | ||
| 2023-08-28 13:57 |
Franchissement de seuils
|
French | 203.1 KB | ||
| 2023-08-07 14:00 |
Communiqués publiés en période d'offre publique d'acquisition / OPA Modalités d…
|
French | 390.4 KB | ||
| 2023-08-04 18:00 |
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
|
French | 160.8 KB | ||
| 2023-08-04 18:00 |
Inside Information / Operations of the issuer (acquisitions, sales...)
|
English | 165.6 KB | ||
| 2023-08-02 18:00 |
Informations privilégiées / Autres communiqués
|
French | 140.7 KB | ||
| 2023-07-06 18:00 |
Informations privilégiées / Autres communiqués
|
French | 140.7 KB |
Automate Your Workflow. Get a real-time feed of all Biocorp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biocorp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biocorp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-09-14 | N/A | Other | Other | 30,000 | 1,050,000.00 EUR |
| 2023-09-14 | N/A | Other | Other | 7,450 | 260,750.00 EUR |
| 2023-09-14 | N/A | Other | Other | 6,000 | 210,000.00 EUR |
| 2023-08-04 | N/A | Other | Sell | 1,998,800 | 69,958,000.00 EUR |
Peer Companies
